Please login to the form below

Not currently logged in

AZ secures capacity for one billion coronavirus vaccine doses

Coronavirus vaccine

Initial agreement to supply 400 million doses of Oxford University’s vaccine

EMA starts review of MorphoSys’ tafasitamab for lymphoma

Drug could challenge Novartis and Gilead’s CAR-T therapies if approved

Gilead, Galapagos dip on mixed ulcerative colitis data

GileadDrug may not work well enough to displace rivals

Roche makes protein degradation play with $135m Vividion deal

Roche Basel SwitzerlandExclusive deal with Vividion includes potential for “multibillion dollar future payments”

Octapharma cleared to start phase 3 trial of Octagam in COVID-19

Interim analysis clinical trialsDrug may stop or slow down deterioration in seriously ill patients

UK government expands coronavirus testing criteria

Those aged five and over will now be eligible for testing

FDA gives Roche’s Tecentriq green light for first-line NSCLC

Roche Basel SwitzerlandCompany enters lucrative and competitive market dominated by Merck/MSD’s rival Keytruda

Trailing Clovis, AstraZeneca gets FDA approval for Lynparza in prostate cancer

LynparzaPhase 3 PROfound trial showed drug cut the risk of disease progression or death by 66%

Moderna’s coronavirus vaccine hits first objectives

Study shows vaccine stimulated COVID-19 antibodies in healthy volunteers

EU flag bodyWho's calling the shots in European healthcare?

Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis

COVID-19 Updates and Daily News

Featured jobs


Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...